STOCK TITAN

POET Technologies Announces Closing of US$400 Million Investment

(Neutral)
(Neutral)
Tags

POET Technologies (NASDAQ: POET) closed a registered direct offering, raising US$400,000,020 from a single institutional investor. The company issued 19,047,620 common shares plus a warrant for the same number of shares at US$21.00 per unit, above the prior US$20.57 close.

The three-year warrant is exercisable at US$26.25, a 25% premium to the offering price. Proceeds will fund a roughly ten-fold manufacturing capacity expansion, R&D, acquisitions, light source business growth, expanded operations, and working capital, supporting POET’s AI and data center photonic interconnect roadmap.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

Positive

  • Raises US$400,000,020 in gross proceeds from institutional investor
  • Equity units priced at US$21.00, above prior US$20.57 close
  • Three-year warrant exercise price of US$26.25, a 25% premium
  • Financing supports roughly 10x expansion in wafer and engine capacity
  • Headcount expanded to 115+ and Singapore lab footprint nearly tripled
  • Adds 20,000 sq ft of assembly space in Malaysia

Negative

  • Immediate dilution from issuing 19,047,620 new common shares
  • Potential future dilution if warrant for 19,047,620 shares is exercised

News Market Reaction – POET

-11.02%
103 alerts
-11.02% News Effect
+5.6% Peak Tracked
-31.3% Trough Tracked
-$302M Valuation Impact
$2.44B Market Cap
0.7x Rel. Volume

On the day this news was published, POET declined 11.02%, reflecting a significant negative market reaction. Argus tracked a peak move of +5.6% during that session. Argus tracked a trough of -31.3% from its starting point during tracking. Our momentum scanner triggered 103 alerts that day, indicating very high trading interest and price volatility. This price movement removed approximately $302M from the company's valuation, bringing the market cap to $2.44B at that time.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -11.0% in the session following this news. The decline reflects a common pattern w...
Analysis

The stock dropped -11.0% in the session following this news. The decline reflects a common pattern where sizeable equity financings trigger pressure despite strategic benefits. POET raised US$400,000,020 through 19,047,620 shares plus matching warrants at a premium, yet the stock fell 22.36%. Past events show similarly sharp reactions to major developments, such as the -47.35% move on order cancellations. Dilution concerns, warrant overhang and execution risks around a ten-fold capacity ramp may have weighed on sentiment.

Key Figures

Gross proceeds: US$400,000,020 Offered securities price: US$21.00 per unit Closing share price: US$20.57 +5 more
8 metrics
Gross proceeds US$400,000,020 Registered direct offering gross proceeds
Offered securities price US$21.00 per unit Price per common share plus warrant unit
Closing share price US$20.57 NASDAQ close on May 14, 2026 used for premium reference
Warrant exercise price US$26.25 per share Exercise price for three-year warrants
Common shares issued 19,047,620 shares Shares sold in registered direct offering
Warrants issued 19,047,620 shares Common shares underlying accompanying warrants
Capacity expansion ten-fold Planned increase in wafer and optical engine capacity
Global headcount more than 115 employees Company-wide headcount after recent hiring

Historical Context

5 past events · Latest: May 14 (Positive)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
May 14 AI partnership Positive +43.1% Strategic Lumilens deal with initial $50M order and up to $500M framework.
May 12 Management change Neutral -1.2% Appointment of experienced semiconductor executive Sandeep Kumar as Chief Operating Officer.
Apr 27 Order cancellation Negative -47.4% Marvell cancels Celestial AI purchase orders over alleged confidentiality breaches.
Apr 14 Tax/PFIC update Positive +3.9% PFIC clarity and plan to redomicile to U.S., mitigating tax impacts for shareholders.
Mar 31 Earnings update Negative -5.7% Q4 2025 net loss of $42.7M on revenue of $341,202 despite strong cash balance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent news has usually moved in the expected direction: positive strategic updates and partnerships have been followed by gains, while negative operational developments and losses have coincided with declines.

Recent Company History

Over the last few months, POET has reported a mix of strategic wins and setbacks. A cancelled Celestial AI order on Apr 27 led to a -47.35% drop, while the Lumilens AI optics deal on May 14 drove a 43.15% gain. Earnings on Mar 31 highlighted a $42.7M net loss but strong cash, with a -5.72% reaction. Management changes and PFIC/tax clarity produced relatively modest moves. Today’s premium-priced capital raise fits into this broader push to fund manufacturing scale-up and AI-focused product roadmaps.

Key Terms

photonic integrated circuits (PICs), registered direct offering, warrant, form f-3, +1 more
5 terms
photonic integrated circuits (PICs) technical
"the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules"
Photonic integrated circuits (PICs) are tiny chips that route and process light instead of electricity, combining multiple optical components on a single piece of material much like an electronic circuit does with transistors and wires. They matter to investors because PICs can enable faster data transmission, lower power use and smaller devices across sectors such as telecom, data centers and sensors, creating potential cost savings, new products and growth opportunities for companies that adopt or make them.
registered direct offering financial
"today announced it had closed its recently announced registered direct offering by issuing19,047,620"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
warrant financial
"and a warrant exercisable for 19,047,620 Common Shares (the “Warrant” and together"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.
form f-3 regulatory
"pursuant to an automatic shelf registration statement on Form F-3 that was filed"
Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.
prospectus supplement regulatory
"The offering was made by means of a prospectus supplement which has been filed"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Secures financing to scale manufacturing and accelerate product leadership in photonic interconnect solutions for frontier AI

TORONTO, May 18, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. (NASDAQ: POET) (the “Corporation”), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today announced it had closed its recently announced registered direct offering by issuing19,047,620 common shares (the “Common Shares”) and a warrant exercisable for 19,047,620 Common Shares (the “Warrant” and together with the Common Shares, the “Offered Securities”). The sale in a non-brokered offering to a single institutional investor raised gross proceeds of US$400,000,020 for the Corporation. The agreed price for each offered security was US$21.00, a premium over the closing price of the Corporation’s common shares as quoted on the NASDAQ Capital Market of US$20.57 on Thursday, May 14, 2026. The accompanying warrant is exercisable for a period of three years from today’s date at an exercise price of US$26.25 per Common Share, representing a 25% premium over the selling price of the offered securities.

The Corporation intends to use the net proceeds from this investment to accelerate its strategic roadmap across three key dimensions of capacity, capability and credibility. This includes the expansion of its manufacturing infrastructure, support for corporate development activities, including targeted acquisitions, scaling up of R&D, acceleration of the light source business, expanding operations, and general working capital.

“We are in the process of expanding our capacity by roughly ten-fold in both wafer production and optical engine assembly in order to support a transition to higher volume manufacturing into 2027,” said Dr. Suresh Venkatesan, Chairman & Chief Executive Officer of POET. “This expansion is being driven by the agreement we announced last week with Lumilens as well as other high-volume opportunities that are near to fruition. In parallel with our manufacturing scale-up, we have accelerated the hiring of engineering, technical and management talent, bringing our total headcount to more than 115 globally. We have also expanded our Singapore lab and office footprint by nearly three times compared to last year and now have 20,000 square feet of assembly space in Malaysia.”

“Corporate development is a high priority for the Company, continued Dr. Venkatesan. “We are actively evaluating and engaging with multiple acquisition and partnership opportunities that can strengthen our engineering capabilities, broaden our product portfolio and enhance our access to strategic technologies and components. Our objective is to build increasingly competitive and differentiated optical solutions spanning optical engines and light source products. By combining internally developed innovations with a strong ecosystem of strategic technology and supply-chain partners, we believe POET is well-positioned to deliver highly integrated, cost-effective and differentiated interconnect products for the AI infrastructure market.”

“Having a strong balance enhances POET’s credibility with customers, partners and suppliers and reinforces the Company’s ability to execute on long-term roadmaps, invest in innovation and is a prerequisite for large-scale commercial engagements in the AI infrastructure market.”

The offering was made pursuant to an automatic shelf registration statement on Form F-3 that was filed with the U.S. Securities and Exchange Commission (the “SEC”) and became automatically effective on January 22, 2026. The offering was made by means of a prospectus supplement which has been filed with the SEC and is available on the SEC’s website located at www.sec.gov. Electronic copies of the prospectus supplement may be obtained, when available, by contacting the Corporation by phone at (416) 368-9411 or by email at legal@poet.tech.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About POET Technologies Inc.
POET is a design and development company offering high-speed optical engines, light source products and custom optical modules to the artificial intelligence systems market and to hyperscale data centers. POET's photonic integration solutions are based on the POET Optical Interposer™, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using advanced wafer-level semiconductor manufacturing techniques. POET's Optical Interposer-based products are lower cost, consume less power than comparable products, are smaller in size and are readily scalable to high production volumes. In addition to providing high-speed (800G, 1.6T and above) optical engines and optical modules for AI clusters and hyperscale data centers, POET has designed and produced novel light source products for chip-to-chip data communication within and between AI servers, the next frontier for solving bandwidth and latency problems in AI systems. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing and sensing applications. POET is headquartered in Toronto, Canada, with operations in Singapore, Penang, Malaysia and Shenzhen, China. More information about POET is available on our website at www.poet-technologies.com

Media Relations Contact:
Adrian Brijbassi
Adrian.Brijbassi@poet.tech
Company Contact:
Thomas R. Mika, EVP & CFO
tm@poet.tech
  

Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" (within the meaning of applicable Canadian securities laws) and "forward-looking statements" (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995). Such statements or information are identified with words such as "anticipate", "believe", "expect", "plan", "intend", "potential", "estimate", "propose", "project", "outlook", "foresee" or similar words suggesting future outcomes or statements regarding any potential outcome. Such statements include, without limitation, the Company's expectations with respect to the use of proceeds of the offering and the Company being able to advance its business objectives. Such forward-looking information or statements are based on a number of risks, uncertainties and assumptions which may cause actual results or other expectations to differ materially from those anticipated and which may prove to be incorrect. Actual results could differ materially due to a number of factors, including, without limitation, potential changes in the Company’s capital needs, changes in production requirements and risks that the Company will not be able to identify or consummate suitable acquisitions and/or partnerships and risks relating to the integration and success of any acquisitions and/or partnerships that are consummated.

For further information concerning these and other risks and uncertainties, refer to the Company's filings on SEDAR+ at www.sedarplus.ca and with the U.S. Securities and Exchange Commission at www.sec.gov. Prospective investors in the Company's securities should not place undue reliance on forward-looking statements because the Company can provide no assurance that such expectations will prove to be correct. Forward-looking information and statements contained in this news release are as of the date of this news release and the Company assumes no obligation to update or revise the forward-looking information and statements except as required by applicable securities laws.
120 Eglinton Avenue, East, Suite 1107, Toronto, ON, M4P 1E2- Tel: 416-368-9411 - Fax: 416-322-5075


FAQ

What did POET (NASDAQ: POET) announce about its US$400 million financing on May 18, 2026?

POET announced closing a registered direct offering raising about US$400,000,020 from a single institutional investor. According to POET, it issued 19,047,620 common shares and a warrant for the same number of shares to fund growth initiatives.

What are the pricing terms of POET stock and warrants in the May 2026 financing?

Each POET offered security was priced at US$21.00, above the prior US$20.57 close. According to POET, the accompanying three-year warrant has a US$26.25 exercise price, a 25% premium to the offering price, potentially adding future capital.

How will POET use the US$400 million proceeds from its May 2026 investment?

POET plans to use proceeds to expand manufacturing, R&D, and corporate development. According to POET, funds will support targeted acquisitions, light source business acceleration, expanded global operations, and general working capital to advance its AI photonic interconnect roadmap.

How does the May 2026 financing support POET’s manufacturing scale-up for AI and data centers?

The financing will help POET expand wafer production and optical engine assembly capacity by about ten-fold into 2027. According to POET, this scale-up supports its Lumilens agreement, other high-volume opportunities, and growing demand for AI infrastructure interconnect solutions.

What operational growth did POET highlight alongside the US$400 million raise?

POET reported accelerated hiring and facility expansion alongside the financing. According to POET, global headcount now exceeds 115, its Singapore lab footprint is nearly tripled versus last year, and it has 20,000 square feet of assembly space in Malaysia to support higher volumes.

What are the potential dilution effects of POET’s May 2026 share and warrant issuance?

The issuance of 19,047,620 new shares creates immediate dilution for existing shareholders. According to POET, an additional 19,047,620 shares may be issued if the three-year warrant is fully exercised, leading to further dilution but also additional capital.

Under which regulatory framework was POET’s May 2026 US$400 million offering conducted?

The offering used an automatic shelf registration statement on Form F-3 that became effective January 22, 2026. According to POET, the securities were sold in a non-brokered registered direct offering to a single institutional investor under this SEC registration framework.